NYtor
NYtor is a Nijmegen, Netherlands-based biotechnology research company, founded in 2007 with 1-10 employees, that provides quantitative PCR services, molecular beacon technology, and antibiotic resistance research to scientific and laboratory clients in the molecular biology and microbiology space.
- Company typePrivate
- Founded2007
- HeadquartersNijmegen, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingServices
What NYtor does
NYtor is a privately held biotechnology research company headquartered in Nijmegen, Netherlands, founded in 2007. The company provides quantitative PCR (qPCR) services, molecular beacon probe-based assays, and antibiotic resistance research, positioning it as a specialty molecular biology and microbiology research services provider.
The firm's product surface is narrow and technical, centered on three service lines: nucleic acid amplification quantification via qPCR, custom molecular beacon probe design and application, and laboratory analysis related to antibiotic resistance phenotypes or genotypes. These offerings suggest a contract-research or technical-services business model serving academic researchers, clinical laboratories, or pharmaceutical/biotech R&D groups in need of molecular assay development and antimicrobial resistance work.
With a documented headcount of 1-10 employees, NYtor operates as a micro-scale specialist. Its revenue mechanics, customer segments, pricing structure, funding history, and management team are not disclosed in the available source material — the second-stage web page returned a loading/verification page with no substantive corporate information. As a result, the company's commercial scale, geographic reach beyond the Netherlands, and go-to-market motion cannot be characterized from available evidence, and the operational footprint should be assumed to be limited absent contradictory signals.
NYtor firmographics
Firmographics- Name
- NYtor
- Website
- https://nytor.nl
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- NYtor is a Nijmegen, Netherlands-based biotechnology research company, founded in 2007 with 1-10 employees, that provides quantitative PCR services, molecular beacon technology, and antibiotic resistance research to scientific and laboratory clients in the molecular biology and microbiology space.
- Ownership category
- akta.pro rank
NYtor industry classification
Industry- Product category
- Biotechnology Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)
- SIC
- Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where NYtor is headquartered
LocationHeadquarters
- HQ city
- Nijmegen
- HQ country
- Netherlands
- HQ region
- Europe
Markets served
NYtor business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
NYtor product offering
Product offeringCore offering
NYtor is a biotechnology research company that performs quantitative PCR (qPCR) analyses, designs and supplies molecular beacon–based detection assays, and delivers antibiotic resistance testing/characterization services. These services are aimed at laboratories and researchers requiring molecular-level nucleic acid detection and antimicrobial resistance profiling.
Differentiator
Problem solved
Functional benefit
Products and services
- Quantitative PCR Services
Companies that use NYtor
Customer profileIdeal customer profiles1 record
NYtor technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NYtor competitors and assessment
Company assessmentBroad incumbents
- QIAGEN: Major provider of qPCR kits, molecular diagnostics, and sample preparation technologies for clinical and research labs; competes in the same PCR/qPCR workflow space NYtor serves.
- Thermo Fisher Scientific (Life Sciences): Offers Applied Biosystems qPCR instruments and reagents plus a broad molecular biology portfolio; overlaps with NYtor in serving qPCR-using researchers and diagnostics labs.
- Cepheid (Danaher): Operates the GeneXpert molecular diagnostics platform with menu including MRSA and antimicrobial resistance tests; relevant comparable for the clinical AMR molecular diagnostics market NYtor targets.
- Bio-Rad Laboratories: Global leader in qPCR instruments, reagents, and digital PCR (ddPCR), directly serving the same molecular biology customer base that NYtor supports. Larger scale and broader menu, but comparable in core technology.
- Eurofins Scientific: Global contract testing organization with antimicrobial resistance and molecular testing services; competes with NYtor for outsourced microbiology and resistance-gene testing contracts.
Direct peers
- TATAA Biocenter: European contract research organization offering qPCR services, training, and assay development; direct competitor for specialized qPCR and molecular beacon-based service contracts.
- Eurogentec: Belgian manufacturer of qPCR reagents, probes, and oligonucleotides with strong European presence; comparable in offering custom molecular biology reagents used in qPCR workflows.
- Integrated DNA Technologies (IDT): Designs and manufactures custom qPCR probes, primers, and assay reagents used in molecular biology research; mirrors NYtor's bead-based/qPCR chemistry expertise at larger scale.
- LGC Biosearch Technologies: Specializes in custom oligonucleotide probes including molecular beacon and qPCR probe design, directly comparable to NYtor's molecular beacon capability and qPCR reagent offerings.
Emerging players
- Mobidiag (now part of Hologic): Developed molecular diagnostic tests for infectious disease and antimicrobial resistance, illustrating the trajectory where qPCR expertise can scale into clinical IVD products.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
NYtor social profiles
Digital presenceNYtor financial estimates
Financial estimateRevenue estimate
Valuation estimate
NYtor leadership team
Management profileNumber of profiles
NYtor funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NYtor M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NYtor
What does NYtor do?
NYtor is a biotechnology research company that performs quantitative PCR (qPCR) analyses, designs and supplies molecular beacon–based detection assays, and delivers antibiotic resistance testing/characterization services. These services are aimed at laboratories and researchers requiring molecular-level nucleic acid detection and antimicrobial resistance profiling.
When was NYtor founded?
NYtor was founded in 2007. It employs 1 to 10 people.
Where is NYtor based?
NYtor is headquartered in Nijmegen, Netherlands, in the Europe region.
Who are NYtor's main competitors?
Broad incumbents on record are QIAGEN, Thermo Fisher Scientific (Life Sciences), Cepheid (Danaher), Bio-Rad Laboratories and Eurofins Scientific. Direct peers are TATAA Biocenter, Eurogentec, Integrated DNA Technologies (IDT) and LGC Biosearch Technologies. Mobidiag (now part of Hologic) is listed as an emerging player.
Does NYtor have an API?
No public API is recorded for NYtor.
What industry is NYtor in?
NYtor's product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 5417 and its SIC code is 8731.